UROGENITAL NEOPLASMS
Clinical trials for UROGENITAL NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new UROGENITAL NEOPLASMS trials appear
Sign up with your email to follow new studies for UROGENITAL NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a new immune drug outsmart Hard-to-Treat tumors?
Disease control Recruiting nowThis trial tests an experimental drug called STAR0602, which is designed to help the immune system attack cancer cells. It is being studied in people with advanced solid tumors that have not responded to standard treatments. The drug is given alone or combined with chemotherapy, …
Matched conditions: UROGENITAL NEOPLASMS
Phase: PHASE1, PHASE2 • Sponsor: Marengo Therapeutics, Inc. • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
New hope for Hard-to-Treat prostate cancer? early trial launches
Disease control Recruiting nowThis study tests a new oral drug called pocenbrodib, alone or with another drug (darolutamide), in 120 men with metastatic castration-resistant prostate cancer (mCRPC). The goal is to find safe doses and see if the combination can slow cancer growth. It is an early-stage trial, s…
Matched conditions: UROGENITAL NEOPLASMS
Phase: PHASE1, PHASE2 • Sponsor: Pathos AI, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Radioactive therapy shows promise for tough prostate cancer
Disease control Recruiting nowThis study tests a new radioactive drug (lutetium rhPSMA-10.1) in men with advanced prostate cancer that has spread and no longer responds to hormone therapy. The goal is to find the safest and most effective dose, and to see if it can shrink tumors or lower PSA levels. About 82 …
Matched conditions: UROGENITAL NEOPLASMS
Phase: PHASE1, PHASE2 • Sponsor: Blue Earth Therapeutics Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New combo aims to shrink penile cancer before surgery
Disease control Recruiting nowThis phase 2 trial tests whether giving pembrolizumab (Keytruda) plus chemotherapy (carboplatin and paclitaxel) before surgery can completely eliminate advanced penile cancer in the penis and lymph nodes. About 27 men with resectable, node-positive penile cancer will receive the …
Matched conditions: UROGENITAL NEOPLASMS
Phase: PHASE2 • Sponsor: The Netherlands Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New hope for kidney cancer: Real-World study tests vorolanib as Second-Line therapy
Disease control Recruiting nowThis study looks at how well the drug vorolanib works for people with advanced kidney cancer that cannot be removed by surgery or has spread. It is for patients who need a second treatment after their first one stopped working. The study will track how long the cancer stays under…
Matched conditions: UROGENITAL NEOPLASMS
Sponsor: Jinling Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New PET scan agent could spot kidney cancer more accurately
Diagnosis Recruiting nowThis study tests a new radioactive imaging agent called [18F]RCCB6 for PET/CT scans to see if it can better detect kidney cancer, especially the most common type, clear cell renal cell carcinoma. Researchers will enroll 300 adults with confirmed or suspected kidney cancer. The go…
Matched conditions: UROGENITAL NEOPLASMS
Phase: PHASE2 • Sponsor: RenJi Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 08:07 UTC
-
Scientists launch Largest-Ever study of rare bladder and genital cancers
Knowledge-focused Recruiting nowThis study follows 1,100 adults with rare urinary tract cancers, such as unusual bladder, kidney, testicular, or penile cancers. Researchers will collect medical records, blood and tumor samples, and imaging over many years to understand how these cancers grow and respond to trea…
Matched conditions: UROGENITAL NEOPLASMS
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Aug 12, 2026 00:00 UTC
-
New test may predict immunotherapy success in bladder cancer
Knowledge-focused Recruiting nowThis study is testing a new lab test called SPHERTEST to see if it can predict how well bladder cancer patients will respond to immunotherapy. Researchers will take blood and tumor samples from 32 patients with advanced bladder cancer to see if the test's prediction matches real …
Matched conditions: UROGENITAL NEOPLASMS
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC